Cenobamate
Back to searchMolecule Structure
Scientific Name
Cenobamate
Description of the Drug
Cenobamate is a small molecule drug indicated to treat partial onset seizures in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB06119
http://www.drugbank.ca/drugs/DB06119
Brand Name(s)
Xcopri
Company Owner(s)
Sk Life Science Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | INHIBITOR | CHEMBL2331043 |
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL1682643 | |
| Human Metabolome Database | HMDB0304884 | |
| DrugBank | DB06119 | |
| PubChem: Thomson Pharma | 17420909 | |
| PubChem | 11962412 | |
| DrugCentral | 5355 | |
| Guide to Pharmacology | 10773 | |
| rxnorm | CENOBAMATE | XCOPRI |
